IMVAGGIS 0.03 mg pessary
*Company:
Besins Healthcare (UK) LtdStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may be renewed (B)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 01 June 2022
File name
ie-pl-estriol-pessary-2022-04-04.pdf
Reasons for updating
- New PIL for new product
Updated on 06 April 2022
File name
ie-spc-estriol-pessary-2022-04-04.pdf
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
Legal category:Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Updates in line with the CMDh Core HRT SmPC - addition of angioedema
Updated on 30 October 2020
File name
Imvaggis pessary SPC.pdf
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.8 - Undesirable effects
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 26 May 2020
File name
uk-pl-imvaggis.pdf
Reasons for updating
- Change to section 6 - marketing authorisation holder
- Change to section 6 - manufacturer
Free text change information supplied by the pharmaceutical company
Change address of the marketing authorisation holder in the UK only
Updated on 29 October 2019
File name
ie-pl-estriol-pessary-2018-12-07.pdf
Reasons for updating
- New PIL for new product
Updated on 29 October 2019
File name
ie-spc-estriol-pessary-2018-12-07.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may be renewed (B)
Besins Healthcare (UK) Ltd
 Ltd.webp)
Address:
Lion Court, 25 Procter Street, Holborn, London, WC1V 6NY, UKMedical Information E-mail:
besins@eu.propharmagroup.comTelephone:
+44 (0) 203 862 0920Website:
https://www.besinshealthcare.co.ukMedical Information Direct Line:
+ 353 (01) 4004466